Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Obesity

Free Subscription Articles published in Diabetes Metab Retrieve available abstracts of 12 articles: HTML format

Single Articles

September 2025
1. SCHEEN AJ
   GLP-1 receptor agonists, body composition, skeletal muscle and risk of sarcopaenia: from promising findings in animal models to debated concern in human studies.
   Diabetes Metab. 2025;51:101681.
   PubMed     Abstract available
   
   
   May 2025
2. HANKOSKY ER, Desai K, Chinthammit C, Grabner M, et al
   Real-world use and effectiveness of tirzepatide among people without evidence of type 2 diabetes in the United States.
   Diabetes Metab. 2025;51:101636.
   PubMed     Abstract available
   
   
   March 2025
3. SCHEEN AJ
   Weight loss therapy and addiction: Increased risk after bariatric surgery but reduced risk with GLP-1 receptor agonists.
   Diabetes Metab. 2025;51:101612.
   PubMed     Abstract available
   
   
   February 2025
4. DISSE E, Aron-Wisnewsky J, Jacobi D, Clement K, et al
   Semaglutide 2.4 mg in French people living with Class 3 obesity and comorbidities: Baseline characteristics and real-world safety data.
   Diabetes Metab. 2025 Feb 17:101625. doi: 10.1016/j.diabet.2025.101625.
   PubMed     Abstract available
   
   
   January 2025
5. YUAN F, Fang D, Xu H, Nie Y, et al
   One-hour post-load glucose is associated with biopsy-proven metabolic dysfunction-associated steatotic liver disease in obese individuals.
   Diabetes Metab. 2025;51:101588.
   PubMed     Abstract available
   
   
   December 2024
6. BROUSSE Y, Gerardin P, Filali D, Lenclume V, et al
   Obesity rather than diabetes impacted severe Covid-19 on reunion island: A retrospective cohort study from a frontline hospital, 2020-2021.
   Diabetes Metab. 2024;51:101601.
   PubMed     Abstract available
   
   
   September 2024
7. WEAN J, Baranwal S, Miller N, Shin JH, et al
   Gut-muscle communication links FGF19 levels to the loss of lean muscle mass following rapid weight loss.
   Diabetes Metab. 2024;50:101570.
   PubMed     Abstract available
   
   
   
8. KOVAC L, Gancheva S, Jahnert M, Sehgal R, et al
   Different effects of bariatric surgery on epigenetic plasticity in skeletal muscle of individuals with and without type 2 diabetes.
   Diabetes Metab. 2024;50:101561.
   PubMed     Abstract available
   
   
   December 2023
9. KOUIDRAT Y, Collen LL, Vaxillaire M, Dechaume A, et al
   Dominant PDX1 deficiency causes highly penetrant diabetes at different ages, associated with obesity and exocrine pancreatic deficiency: lessons for precision medicine.
   Diabetes Metab. 2023 Dec 21:101507. doi: 10.1016/j.diabet.2023.101507.
   PubMed     Abstract available
   
   
   November 2023
10. LAFARGE JC, Aron-Wisnewsky J, Pattou F, Cucherat M, et al
    French National Authority for Health assessment of metabolic surgery for type 2 diabetes remission- a meta-analysis in patients with class I to III obesity.
    Diabetes Metab. 2023 Nov 22:101495. doi: 10.1016/j.diabet.2023.101495.
    PubMed     Abstract available
    
    
    May 2023
11. YANG Z, Shen P, Qu Y, Xu L, et al
    Baseline and longitudinal trajectories of body-mass index and all-cause mortality among patients with type 2 diabetes.
    Diabetes Metab. 2023;49:101426.
    PubMed     Abstract available
    
    
    March 2023
12. AMADOU C, Heude B, de Lauzon-Guillain B, Lioret S, et al
    Early origins of metabolic and overall health in young adults: An outcome-wide analysis in a general cohort population.
    Diabetes Metab. 2023;49:101414.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Obesity is free of charge.